Rossi Michael J 4
4 · Y-mAbs Therapeutics, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
Rossi Michael J
DirectorPRESIDENT & CEO
Transactions
- Sale
Common Stock
2025-03-07$5.20/sh−3,917$20,368→ 137,083 total
Footnotes (1)
- [F1]Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.